SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Allogene Therapeutics Inc. (ALLO) on Thursday reported a loss of $38.8 million in its fourth quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 17 cents.
The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.
For the year, the company reported that its loss narrowed to $190.9 million, or 87 cents per share.
In the final minutes of trading on Thursday, the company's shares hit $2.47. A year ago, they were trading at $2.06.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALLO at https://www.zacks.com/ap/ALLO
/An%20image%20of%20a%20Tesla%20humanoid%20robot%20in%20front%20of%20the%20company%20logo%20Around%20the%20World%20Photos%20via%20Shutterstock.jpg)
/Facebook%20like%20button%20on%20keyboard%20by%20athree23%20via%20Pixabay.jpg)
/A%20SoFi%20logo%20on%20an%20office%20building%20by%20Tada%20Images%20via%20Shutterstock.jpg)